Since its appearance in Wuhan in mid-December 2019, acute respiratory syndrome coronavirus 2 (SARS-CoV-2) related 19 coronavirus disease (COVID-19) has spread dramatically worldwide. It soon became apparent that the incidence of pediatric COVID-19 was much lower than the adult form. Morbidity in children is characterized by a variable clinical presentation and course. Symptoms are similar to those of other acute respiratory viral infections, the upper airways being more affected than the lower airways. Thus far, over 90% of children who tested positive for the virus presented mild or moderate symptoms and signs. Most children were asymptomatic, and only a few cases were severe, unlike in the adult population. Deaths have been rare and occurred mainly in children with underlying morbidity. Factors as reduced angiotensin-converting enzyme receptor expression, increased activation of the interferon-related innate immune response, and trained immunity have been implicated in the relative resistance to COVID-19 in children, however the underlying pathogenesis and mechanism of action remain to be established. While at the pandemic outbreak, mild respiratory manifestations were the most frequently described symptoms in children, subsequent reports suggested that the clinical course of COVID-19 is more complex than initially thought. Thanks to the experience acquired in adults, the diagnosis of pediatric SARS-CoV-2 infection has improved with time. Data on the treatment of children are sparse, however, several antiviral trials are ongoing. The purpose of this narrative review is to summarize current understanding of pediatric SARS-CoV-2 infection and provide more accurate information for healthcare workers and improve the care of patients.
【저자키워드】 COVID-19, SARS-CoV-2, therapy, children, adolescents, drugs, Novel coronavirus, chest imaging, 【초록키워드】 Treatment, coronavirus disease, coronavirus, pandemic, Pathogenesis, Trial, innate immune response, Immunity, Antiviral, SARS-COV-2 infection, pediatric, Diagnosis, Symptom, virus, healthcare worker, Spread, Adults, Clinical course, Asymptomatic, outbreak, Wuhan, morbidity, Mild, receptor, incidence, upper airway, information, mechanism of action, expression, Care, moderate, patients, respiratory viral infections, Angiotensin-converting enzyme, manifestation, acute respiratory syndrome, Activation, Factor, complex, lower airways, positive, while, MOST, IMPROVE, thought, Course, tested, described, affected, occurred, subsequent, reduced, characterized, suggested, implicated, mild respiratory, much lower,